Therapeutic Goods Order No. 88 - Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products
Administered by
- Department of Health and Aged Care
This item is authorised by the following title:
Downloads
Access downloadable documents for version effective 28 May 2013 - 29 September 2021
Legislative instrument
Word:
1 VolumeExplanatory statement
Word:
1 VolumeSupporting material
Word:
2 Documents- Therapeutic Goods Order No. 88 - Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products Volume 1.DOCXStatement of Compatibility with Human Rights and Regulation Impact Statement17 KB1 page
- Therapeutic Goods Order No. 88 - Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products Volume 2.DOCXStatement of Compatibility with Human Rights and Regulation Impact Statement387 KB48 pages
PDF:
2 Documents- Therapeutic Goods Order No. 88 - Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products Volume 1.pdfStatement of Compatibility with Human Rights and Regulation Impact Statement290 KB1 page
- Therapeutic Goods Order No. 88 - Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products Volume 2.pdfStatement of Compatibility with Human Rights and Regulation Impact Statement1014 KB48 pages
For transitional arrangements relating to the repeal of this instrument, see section 7 of the Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021 and section 7 of the Therapeutic Goods (Standards for Biologicals—General and Specific Requirements) (TGO 109) Order 2021.